INS and type 2 diabetes mellitus: In this observational study, the authors analyzed the effects of dulaglutide in patients with T2DM and, after 12 months of treatment, observed a significant reduction in HbA1c by 2%, a decrease in body weight by 3.5 kg, and a reduction in insulin dosage among patients [33].